RECEF (RECEF)

Pipeline catalysts loom: Discussions on social media highlight Recursion Pharmaceuticals' advancing AI-driven drug discovery efforts, with attention on upcoming H2 2026 readouts for programs like REC-4881 and REC-1245. Observers note the company's partnerships with major players and its proprietary …

SpaceX stock whipsawed through a volatile week, swinging from an all-time low to a sharp rebound and closing at a new low, as investors braced for the newly public company's first earnings report and a major share unlock.

Reddit reported second-quarter earnings that beat on the top and the bottom, and gave a revenue forecast that topped estimates.

The company struck the perfect chord of blockbuster cloud-computing results and restrained capex spending.

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is positioned to benefit from a new five-year, US$66.9 billion US Government strategy aimed at strengthening national defences against pandemics, antimicrobial resistance and other major biological threats.